FDA approves new treatment for adults with relapsed follicular lymphoma

By Newsroom America Feeds at 14 Sep 2017

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm576129.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL